175 related articles for article (PubMed ID: 29510205)
21. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
[TBL] [Abstract][Full Text] [Related]
22. BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination.
Chen F; Yan Q; Yu Y; Wu MX
J Control Release; 2017 Jun; 255():36-44. PubMed ID: 28390901
[TBL] [Abstract][Full Text] [Related]
23. Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles.
Kines RC; Zarnitsyn V; Johnson TR; Pang YY; Corbett KS; Nicewonger JD; Gangopadhyay A; Chen M; Liu J; Prausnitz MR; Schiller JT; Graham BS
PLoS One; 2015; 10(3):e0120797. PubMed ID: 25785935
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
[TBL] [Abstract][Full Text] [Related]
25. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
Shah V; Choudhury BK
AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
[TBL] [Abstract][Full Text] [Related]
26. Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique.
Donnelly RF; Majithiya R; Singh TR; Morrow DI; Garland MJ; Demir YK; Migalska K; Ryan E; Gillen D; Scott CJ; Woolfson AD
Pharm Res; 2011 Jan; 28(1):41-57. PubMed ID: 20490627
[TBL] [Abstract][Full Text] [Related]
27. Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations.
Pearton M; Allender C; Brain K; Anstey A; Gateley C; Wilke N; Morrissey A; Birchall J
Pharm Res; 2008 Feb; 25(2):407-16. PubMed ID: 17671832
[TBL] [Abstract][Full Text] [Related]
28. Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine.
Kim NW; Lee MS; Kim KR; Lee JE; Lee K; Park JS; Matsumoto Y; Jo DG; Lee H; Lee DS; Jeong JH
J Control Release; 2014 Apr; 179():11-7. PubMed ID: 24462900
[TBL] [Abstract][Full Text] [Related]
29. Microneedle-mediated delivery of viral vectored vaccines.
Zaric M; Ibarzo Yus B; Kalcheva PP; Klavinskis LS
Expert Opin Drug Deliv; 2017 Oct; 14(10):1177-1187. PubMed ID: 27591122
[TBL] [Abstract][Full Text] [Related]
30. A dual-delivery platform for vaccination using antigen-loaded nanoparticles in dissolving microneedles.
Braz Gomes K; D'Souza B; Vijayanand S; Menon I; D'Souza MJ
Int J Pharm; 2022 Feb; 613():121393. PubMed ID: 34929312
[TBL] [Abstract][Full Text] [Related]
31. A simple method of microneedle array fabrication for transdermal drug delivery.
Kochhar JS; Goh WJ; Chan SY; Kang L
Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721
[TBL] [Abstract][Full Text] [Related]
32. Cancer gene therapy mediated by RALA/plasmid DNA vectors: Nitrogen to phosphate groups ratio (N/P) as a tool for tunable transfection efficiency and apoptosis.
Neves AR; Sousa A; Faria R; Albuquerque T; Queiroz JA; Costa D
Colloids Surf B Biointerfaces; 2020 Jan; 185():110610. PubMed ID: 31711736
[TBL] [Abstract][Full Text] [Related]
33. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
34. Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination.
Balmert SC; Carey CD; Falo GD; Sethi SK; Erdos G; Korkmaz E; Falo LD
J Control Release; 2020 Jan; 317():336-346. PubMed ID: 31756393
[TBL] [Abstract][Full Text] [Related]
35. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
[TBL] [Abstract][Full Text] [Related]
36. A flexible microneedle array as low-voltage electroporation electrodes for in vivo DNA and siRNA delivery.
Wei Z; Zheng S; Wang R; Bu X; Ma H; Wu Y; Zhu L; Hu Z; Liang Z; Li Z
Lab Chip; 2014 Oct; 14(20):4093-102. PubMed ID: 25182174
[TBL] [Abstract][Full Text] [Related]
37. Hollow microneedle arrays for intradermal drug delivery and DNA electroporation.
Daugimont L; Baron N; Vandermeulen G; Pavselj N; Miklavcic D; Jullien MC; Cabodevila G; Mir LM; Préat V
J Membr Biol; 2010 Jul; 236(1):117-25. PubMed ID: 20652559
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and drug release systems based on microneedle arrays in breast cancer therapy.
Khan S; Hasan A; Attar F; Babadaei MMN; Zeinabad HA; Salehi M; Alizadeh M; Hassan M; Derakhshankhah H; Hamblin MR; Bai Q; Sharifi M; Falahati M; Ten Hagen TLM
J Control Release; 2021 Oct; 338():341-357. PubMed ID: 34428480
[TBL] [Abstract][Full Text] [Related]
39. Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.
McCrudden MT; Torrisi BM; Al-Zahrani S; McCrudden CM; Zaric M; Scott CJ; Kissenpfennig A; McCarthy HO; Donnelly RF
J Pharm Pharmacol; 2015 Mar; 67(3):409-25. PubMed ID: 24673568
[TBL] [Abstract][Full Text] [Related]
40. 2
Pawar S; Shende P
Biomed Microdevices; 2020 Feb; 22(1):19. PubMed ID: 32076890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
